News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Child Receives Transgenic Skin Over Most of His Body
Ruth Williams | Nov 8, 2017
A combination gene-and-cell therapy has given a boy with a grievous skin disease a new lease on life, and has resolved a dermatology debate to boot.
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas.
Synthetic Stem Cells Regenerate Heart Tissue in Mice
Diana Kwon | Jun 1, 2017
These engineered “cells” were made from the secretions and membranes of human mesenchymal stem cells.
Infographic: How to Make an Artificial Stem Cell
Diana Kwon | May 31, 2017
See researchers' recipe for synthetic mesenchymal stem cells, which showed cardiac regenerative potential in mice.
New FDA Pathway to Accelerate Development of Cell Therapies
Jef Akst | May 22, 2017
Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.
Cell Lines Gain Cancer-Related Mutations
Kerry Grens | Apr 27, 2017
A screen of human embryonic stem cell lines finds several that accumulated changes in the gene
including aberrations commonly seen in cancer.
First Clinic-Ready Stem Cell Repository
Kerry Grens | Apr 6, 2017
The UK Stem Cell Bank offers several lines derived from human embryonic tissue.
Suicide Switch for Transplanted Stem Cells
Abby Olena | Mar 2, 2017
Researchers use an inducible gene to limit tumor growth from human iPSCs transplanted into mice.
Regulators OK Clinical Trials Using Donor Stem Cells
Kerry Grens | Feb 6, 2017
Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.
Q&A: Improving Cardiac Cell Therapy
Kerry Grens | Nov 15, 2016
caught up with cardiac stem cell researcher Mark Sussman to get his thoughts on the American Heart Association’s Scientific Sessions meeting.